ODDB.org: Open Drug Database

Mepha Pharma AG - Mometason-Mepha Nasenspray, Suspension

Swissmedic Registration	63248	Sequence	01
Product name	Mometason-Mepha Nasenspray	Description	Suspension
ATC-Classification	R01AD09	ATC-Description	Mometasone
Introduction of Sequence	07.02.2014

Composition

mometasoni-17 furoas 50 µg ut mometasoni-17 furoas monohydricus, cellulosum microcristallinum et carmellosum natricum, glycerolum, polysorbatum 80, acidum citricum monohydricum, natrii citras dihydricus, benzalkonii chloridum 20 µg, aqua ad iniectabile, ad suspensionem pro dosi, doses pro vase 140.

Packungsbestandteile

Galenic Form

Nasal spray

Excipiens

Active Agent	Dose
Mometasoni-17 Furoas	50 µg

BAG: Active Agent	Dose
Mometasone 17 Furoate	0.05 mg

Inactive agents		additional_information
Benzalkonii Chloridi Solutio		conserv.

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001	140 unidose(s)	7.73	17.65	B	SL	Yes
002	3 x 140	19.70	37.85	B	SL	Yes

2025	©ywesee GmbH